Neovare’s™ is a siParadigm Company. siParadigm exists to combine mutual trust with personalized solutions to set the standard for service excellence. Our values are Accountability, Empathy, and Continuous Improvement.
Neovare™ is dedicated to provide patients and healthcare professionals with reliable, high quality and affordable hereditary cancer testing solutions. This is backed by siParadigm’s proven know-how and 17 years of clinical oncology expertise through service, integrity and innovation.
We are a top-ranked clinical lab. certified by the Clinical Laboratory Improvement Amendments and accredited by the College of American Pathologists. Our Proprietary dual platform (NGS and microarray) panels design assesses hereditary cancer risk based on consensus national medical society’s guidelines. Select results are confirmed by Sanger sequencing and/or RNA testing. This avoids multiple sampling and saves time, effort and costs.